Drugs / Adenoviral Vector-Mediated Gene Transfer
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00004498 | Jul 1998 → Sep 2000 | ornithine carbamoyltransferase deficiency | University of Pennsylvania | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adenoviral Vector-Mediated Gene Transfer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004498 ↗ |
| Route | Other | “Patients then receive adenoviral vector mediated gene transfer intravascularly over 30 minutes.” NCT00004498 ↗ |